PT  - JOURNAL ARTICLE
AU  - Theodore Pincus
AU  - Yusuf Yazici
AU  - Ronald van Vollenhoven
TI  - Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials.
DP  - 2006 Dec 01
TA  - The Journal of Rheumatology
PG  - 2372--2375
VI  - 33
IP  - 12
4099  - http://www.jrheum.org/content/33/12/2372.short
4100  - http://www.jrheum.org/content/33/12/2372.full
SO  - J Rheumatol2006 Dec 01; 33